Hypertension burden, treatment, and control among people with HIV at a clinical care center in the Southeastern US, 2014–2019

References

• Althoff, K. N., McGinnis, K. A., Wyatt, C. M., Freiberg, M. S., Gilbert, C., Oursler, K. K., Rimland, D., Rodriguez-Barradas, M. C., Dubrow, R., Park, L. S., Skanderson, M., Shiels, M. S., Gange, S. J., Gebo, K. A., & Justice, A. C. (2015). Comparison of risk and age at diagnosis of myocardial infarction, Clinical Infectious Diseasesd-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults. Clinical Infectious Diseases, 60(4), 627–638. https://doi.org/10.1093/cid/ciu869
   PubMed Web of Science ®Google Scholar
• Armah, K. A., Chang, C. C. H., Baker, J. V., Ramachandran, V. S., Budoff, M. J., Crane, H. M., Gibert, C. L., Goetz, M. B., Leaf, D. A., McGinnis, K. A., Oursler, K. K., Rimland, D., Rodriguez-Barradas, M. C., Sico, J. J., Warner, A. L., Hsue, P. Y., Kuller, L. H., Justice, A. C., & Freiberg, M. S. (2014). Prehypertension, hypertension, and the risk of acute myocardial infarction in HIV-infected and -uninfected veterans. Clinical Infectious Diseases, 58(1), 121–129. https://doi.org/10.1093/cid/cit652
   PubMed Web of Science ®Google Scholar
• Bigna, J. J., Ndoadoumgue, A. L., Nansseu, J. R., Tochie, J. N., & Nyaga, U. F. (2020). Global burden of hypertension among people living with HIV in the era of increased life expectancy: a systematic review and meta-analysis. Journal of Hypertension, 38(9), 1659–1668. https://doi.org/10.1097/HJH.0000000000002446
   PubMed Web of Science ®Google Scholar
• Burkholder, G. A., Tamhane, A. R., Safford, M. M., Muntner, P. M., Willig, A. L., Willig, J. H., Raper, J. L., Saag, M. S., & Mugavero, M. J. (2018). Racial disparities in the prevalence and control of hypertension among a cohort of HIV-infected patients in the southeastern United States. PLoS ONE, 13(3), e0194940. https://doi.org/10.1371/journal.pone.0194940
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2020a). BRFSS Prevalence & Trends Data. https://www.cdc.gov/brfss/brfssprevalence/
   Google Scholar
• Centers for Disease Control and Prevention. (2020b). HIV Surveillance Report, 2018 (Updated). 31. http://www.cdc.gov/hiv/surveillance/resources/reports/2009report/index.htm#1
   Google Scholar
• Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., & Roccella, E. J. (2003). Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension, 42(6), 1206–1252. https://doi.org/10.1161/01.HYP.0000107251.49515.c2
   PubMed Web of Science ®Google Scholar
• Davy-Mendez, T., Napravnik, S., Hogan, B. C., Althoff, K. N., Gebo, K. A., Moore, R. D., Horberg, M. A., Silverberg, M. J., Gill, M. J., Crane, H. M., Marconi, V. C., Bosch, R. J., Colasanti, J. A., Sterling, T. R., Mathews, W. C., Mayor, A. M., Nanditha, N. G. A., Buchacz, K., Li, J., … Coburn, S. (2021). Hospitalization rates and causes Among persons With HIV in the United States and Canada, 2005–2015. The Journal of Infectious Diseases, 223(12), 2113–2123. https://doi.org/10.1093/infdis/jiaa661
   PubMed Web of Science ®Google Scholar
• De Socio, G. V., Ricci, E., Maggi, P., Parruti, G., Celesia, B. M., Orofino, G., Madeddu, G., Martinelli, C., Menzaghi, B., Taramasso, L., Bonfanti, P., Pucci, G., & Schillaci, G. (2017). Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients. Journal of Hypertension, 35(2), 409–416. https://doi.org/10.1097/HJH.0000000000001150
   PubMed Web of Science ®Google Scholar
• Drozd, D. R., Kitahata, M. M., Althoff, K. N., Zhang, J., Gange, S. J., Napravnik, S., Burkholder, G. A., Mathews, W. C., Silverberg, M. J., Sterling, T. R., Heckbert, S. R., Budoff, M. J., Van Rompaey, S., Delaney, J. A. C., Wong, C., Tong, W., Palella, F. J., Elion, R. A., Martin, J. N., Brooks, J. T, & Crane, H. M. (2017). Increased risk of myocardial infarction in HIV-infected individuals in North America compared with the general population. JAIDS Journal of Acquired Immune Deficiency Syndromes, 75(5), 568–576. https://doi.org/10.1097/QAI.0000000000001450
   PubMed Web of Science ®Google Scholar
• Duncan, A. D., Goff, L. M., & Peters, B. S. (2018). Type 2 diabetes prevalence and its risk factors in HIV: A cross-sectional study. PLoS ONE, 13(3), https://doi.org/10.1371/journal.pone.0194199
   Google Scholar
• Feinstein, M. J., Bahiru, E., Achenbach, C., Longenecker, C. T., Hsue, P., So-Armah, K., Freiberg, M. S., & Lloyd-Jones, D. M. (2016). Patterns of cardiovascular mortality for HIV-infected adults in the United States: 1999 to 2013. The American Journal of Cardiology, 117(2), 214–220. https://doi.org/10.1016/j.amjcard.2015.10.030
   PubMed Web of Science ®Google Scholar
• Feinstein, M. J., Hsue, P. Y., Benjamin, L. A., Bloomfield, G. S., Currier, J. S., Freiberg, M. S., Grinspoon, S. K., Levin, J., Longenecker, C. T., & Post, W. S. (2019). Characteristics, prevention, and management of cardiovascular disease in people living With HIV: A scientific statement from the American heart association. Circulation, 140(2), e98–e124. https://doi.org/10.1161/CIR.0000000000000695
   PubMed Web of Science ®Google Scholar
• Hanna, D. B., Lin, J., Post, W. S., Hodis, H. N., Xue, X., Anastos, K., Cohen, M. H., Gange, S. J., Haberlen, S. A., Heath, S. L., Lazar, J. M., Liu, C., Mack, W. J., Ofotokun, I., Palella, F. J., Tien, P. C., Witt, M. D., Landay, A. L., Kingsley, L. A., … Kaplan, R. C. (2017). Association of macrophage inflammation biomarkers with progression of subclinical carotid artery atherosclerosis in HIV-infected women and men. The Journal of Infectious Diseases, 215(9), 1352–1361. https://doi.org/10.1093/infdis/jix082
   PubMed Web of Science ®Google Scholar
• Hogg, R. S., Eyawo, O., Collins, A. B., Zhang, W., Jabbari, S., Hull, M. W., Lima, V. D., Ahmed, T., Kendall, C. E., Althoff, K. N., Justice, A. C., Barrios, R., Shoveller, J., & Montaner, J. S. G. (2017). Health-adjusted life expectancy in HIV-positive and HIV-negative men and women in British Columbia, Canada: a population-based observational cohort study. The Lancet HIV, 4(6), e270–e276. https://doi.org/10.1016/S2352-3018(17)30029-2
   PubMed Web of Science ®Google Scholar
• James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, H., & Lackland, D. T. (2015). Evidence-Based Guideline for the Management of High Blood Pressure in Adults in 2014: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). Bangladesh Journal of Medicine, 311(5), 1–2. https://doi.org/10.3329/bjmed.v25i1.25069
   Google Scholar
• Kuller, L. H., Tracy, R., Belloso, W., De Wit, S., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., Paton, N. I., & Neaton, J. D. (2008). Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Medicine, 5(10), e203–1508. https://doi.org/10.1371/journal.pmed.0050203
   PubMed Web of Science ®Google Scholar
• Langness, J., Cook, P. F., Gill, J., Boggs, R., & Netsanet, N. (2014). Comparison of adherence rates for antiretroviral, blood pressure, or mental health medications for HIV-positive patients at an academic medical center outpatient pharmacy. Journal of Managed Care Pharmacy, 20(8), 809–814. https://doi.org/10.18553/jmcp.2014.20.8.809
   PubMed Web of Science ®Google Scholar
• Manner, I. W., Baekken, M., Oektedalen, O., & Os, I. (2012). Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study. Blood Pressure, 21(5), 311–319. https://doi.org/10.3109/08037051.2012.680742
   PubMed Web of Science ®Google Scholar
• McLaughlin, M. M., Ma, Y., Scherzer, R., Rahalkar, S., Martin, J. N., Mills, C., Milush, J., Deeks, S. G., & Hsue, P. Y. (2020). Association of viral persistence and atherosclerosis in adults With treated HIV infection. JAMA Network Open, 3(10), e2018099. https://doi.org/10.1001/jamanetworkopen.2020.18099
   PubMed Web of Science ®Google Scholar
• Mdodo, R., Frazier, E. L., Dube, S. R., Mattson, C. L., Sutton, M. Y., Brooks, J. T., & Skarbinski, J. (2015). Cigarette smoking prevalence Among adults With HIV compared With the general adult population in the United States. Annals of Internal Medicine, 162(5), 335–344. https://doi.org/10.7326/M14-0954
   PubMed Web of Science ®Google Scholar
• Myerson, M., Poltavskiy, E., Armstrong, E. J., Kim, S., Sharp, V., & Bang, H. (2014). Prevalence, treatment, and control of dyslipidemia and hypertension in 4278 HIV outpatients. JAIDS Journal of Acquired Immune Deficiency Syndromes, 66(4), 370–377. https://doi.org/10.1097/QAI.0000000000000168
   PubMed Web of Science ®Google Scholar
• Napravnik, S., Eron, J. J., Mckaig, R. G., Heine, A. D., Menezes, P., & Quinlivan, E. B. (2006). Factors associated with fewer visits for HIV primary care at a tertiary care center in the Southeastern U.S. AIDS Care, 18(sup1), 45–50. https://doi.org/10.1080/09540120600838928
   Web of Science ®Google Scholar
• Okeke, N. L., Davy, T., Eron, J. J., & Napravnik, S. (2016). Hypertension Among HIV-infected Patients in Clinical Care, 1996-2013. Clinical Infectious Diseases, 63(2), 242–248. https://doi.org/10.1093/cid/ciw223
   PubMed Web of Science ®Google Scholar
• Okeke, N. L., Schafer, K. R., Meissner, E. G., Ostermann, J., Shah, A. D., Ostasiewski, B., Phelps, E., Kieler, C. A., Oladele, E., Garg, K., Naggie, S., Bloomfield, G. S., & Bosworth, H. B. (2020). Cardiovascular disease risk management in persons With HIV: Does clinician specialty matter? Open Forum Infectious Diseases, 7(9), https://doi.org/10.1093/ofid/ofaa361
   Google Scholar
• Richardson, K. K., Bokhour, B., McInnes, D. K., Yakovchenko, V., Okwara, L., Midboe, A. M., Skolnik, A., Vaughan-Sarrazin, M., Asch, S. M., Gifford, A. L., & Ohl, M. E. (2016). Racial disparities in HIV care extend to common comorbidities: Implications for implementation of interventions to reduce disparities in HIV care. Journal of the National Medical Association, 108(4), 201–210.e3. https://doi.org/10.1016/j.jnma.2016.08.001
   PubMed Web of Science ®Google Scholar
• Ross, A. C., Rizk, N., O’Riordan, M. A., Dogra, V., El-Bejjani, D., Storer, N., Harrill, D., Tungsiripat, M., Adell, J., & McComsey, G. A. (2009). Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy. Clinical Infectious Diseases, 49(7), 1119–1127. https://doi.org/10.1086/605578
   PubMed Web of Science ®Google Scholar
• Shah, A. S. V., Stelzle, D., Lee, K. K., Beck, E. J., Alam, S., Clifford, S., Longenecker, C. T., Strachan, F., Bagchi, S., Whiteley, W., Rajagopalan, S., Kottilil, S., Nair, H., Newby, D. E., McAllister, D. A., & Mills, N. L. (2018). Global burden of atherosclerotic cardiovascular disease in people living With HIV. Circulation, 138(11), 1100–1112. https://doi.org/10.1161/CIRCULATIONAHA.117.033369
   PubMed Web of Science ®Google Scholar
• Siddiqui, M., Moore, T. J., Long, D. M., Burkholder, G. A., Willig, A., Wyatt, C., Heath, S., Muntner, P., & Overton, E. T. (2022). Risk factors for incident hypertension within 1 year of initiating antiretroviral therapy Among people with HIV. AIDS Research and Human Retroviruses, 38(9), 735–742. https://doi.org/10.1089/aid.2021.0213
   PubMed Web of Science ®Google Scholar
• So-Armah, K. A., Tate, J. P., Chang, C. C. H., Butt, A. A., Gerschenson, M., Gibert, C. L., Leaf, D., Rimland, D., Rodriguez-Barradas, M. C., Budoff, M. J., Samet, J. H., Kuller, L. H., Deeks, S. G., Crothers, K., Tracy, R. P., Crane, H. M., Sajadi, M. M., Tindle, H. A., Justice, A. C., & Freiberg, M. S. (2016). Do biomarkers of inflammation, monocyte activation, and altered coagulation explain excess mortality between HIV infected and uninfected people? JAIDS Journal of Acquired Immune Deficiency Syndromes, 72(2), 206–213. https://doi.org/10.1097/QAI.0000000000000954
   PubMed Web of Science ®Google Scholar
• Tate, T., Willig, A. L., Willig, J. H., Raper, J. L., Moneyham, L., Kempf, M. C., Saag, M. S., & Mugavero, M. J. (2012). Hiv infection and obesity: Where Did All the wasting Go? Antiviral Therapy, 17(7), 1281–1289. https://doi.org/10.3851/IMP2348
   PubMed Web of Science ®Google Scholar
• Trickey, A., May, M. T., Vehreschild, J.-J., Obel, N., Gill, M. J., Crane, H. M., Boesecke, C., Patterson, S., Grabar, S., Cazanave, C., Cavassini, M., Shepherd, L., Monforte, A. d. A., van Sighem, A., Saag, M., Lampe, F., Hernando, V., Montero, M., Zangerle, R., … Sterne, J. A. C. (2017). Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. The Lancet HIV, 4(8), e349–e356. https://doi.org/10.1016/S2352-3018(17)30066-8
   PubMed Web of Science ®Google Scholar
• van Zoest, R. A., Wit, F. W., Kooij, K. W., van der Valk, M., Schouten, J., Kootstra, N. A., Wiersinga, W. J., Prins, M., van den Born, B. J. H., & Reiss, P. (2016). Higher prevalence of hypertension in HIV-1-infected patients on combination antiretroviral therapy Is associated With changes in body composition and prior stavudine exposure. Clinical Infectious Diseases, 63(2), 205–213. https://doi.org/10.1093/cid/ciw285
   PubMed Web of Science ®Google Scholar
• Wada, N. I., Bream, J. H., Martínez-Maza, O., Macatangay, B., Galvin, S. R., Margolick, J. B., & Jacobson, L. P. (2016). Inflammatory biomarkers and mortality risk among HIV-suppressed Men: A multisite prospective cohort study. Clinical Infectious Diseases, 63(7), 984–990. https://doi.org/10.1093/cid/ciw409
   PubMed Web of Science ®Google Scholar